Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model

Stem Cells Translational Medicine

Volumn 2, Issue 10, 2013, Pages 797-807

  Scruggs, Brittni A ^a   Semon, Julie A ^a   Zhang, Xiujuan ^a   Zhang, Shijia ^a   Bowles, Annie C ^a,b   Pandey, Amitabh C ^a   Imhof, Kathleen M P ^a   Kalueff, Allan V ^a   Gimble, Jeffrey M ^c   Bunnell, Bruce A ^a,d  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d TULANE UNIVERSITY   (United States)

Author keywords

Adult stem cells; Aging; Cell transplantation; EAE; Experimental autoimmune encephalomyelitis; Experimental models; Mesenchymal stem cells; Multiple sclerosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE DERIVED STEM CELL; AGE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MOUSE; NERVE DEGENERATION; NONHUMAN; PARALYSIS; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; T LYMPHOCYTE;

MUS;

EID: 84884740513     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0026     Document Type: Article

References (42)

1. Goldenberg MM. Multiple sclerosis review. P T 2012;37:175-184.
2. Ascherio A, Munger KL, Lünemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012;8:602-612.
3. Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011;585:3715-3723.
4. Jadasz JJ, Aigner L, Rivera FJ et al. The remyelination Philosopher's Stone: Stem and progenitor cell therapies for multiple sclerosis. Cell Tissue Res 2012;349:331-347.
5. Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: Pathology and pathogenesis. Nat Rev Neurol 2012;8:647-656.
6. Bai L, Lennon DP, Eaton V et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009;57:1192-1203.
7. Bai L, Lennon DP, Caplan AI et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012;15:862-870.
8. Constantin G, Marconi S, Rossi B et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009;27:2624-2635.
9. Freedman MS, Bar-Or A, Atkins HL et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: Consensus report of the International MSCT Study Group. Mult Scler 2010;16:503-510.
10. Gerdoni E, Gallo B, Casazza S et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007;61:219-227.
11. Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755-1761.
12. Kilroy GE, Foster SJ, Wu X et al. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212:702-709.
13. Uccelli A, Benvenuto F, Laroni A et al. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011; 24:59-64.
14. Uccelli A, Zappia E, Benvenuto F et al. Stem cells in inflammatory demyelinating disorders: A dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 2006;6: 17-22.
15. Kassis I, Grigoriadis N, Gowda-Kurkalli B et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008;65:753-761.
16. Bunnell BA, Betancourt AM, Sullivan DE. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther 2010;1:34.
17. Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells as treatment for MS: Progress to date. Mult Scler 2013;19:515-519.
18. Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67:1187-1194.
19. Connick P, Kolappan M, Crawley C et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurol 2012;11:150-156.
20. Alt EU, Senst C, Murthy SN et al. Aging alters tissue resident mesenchymal stem cell properties. Stem Cell Res 2012;8:215-225.
21. Wu W, Niklason L, Steinbacher DM. The effect of age on human adipose derived stem cells. Plast Reconstr Surg 2012.
22. Stolzing A, Jones E, McGonagle D et al. Age-related changes in human bone marrowderived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 2008;129:163-173.
23. Bonab MM, Alimoghaddam K, Talebian F et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14.
24. Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 2010;16:445-453.
25. Kretlow JD, Jin YQ, Liu W, et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008;9:60.
26. Zhou S, Greenberger JS, Epperly MW et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008;7:335-343.
27. Pandey AC, Semon JA, Kaushal D et al. MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells. Stem Cell Res Ther 2011;2:49.
28. Sonobe Y, Jin S, Wang J et al. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J Exp Med 2007;213:329-339.
29. Scruggs BA, Bowles AC, Zhang X et al. High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice. Behav Brain Res 2013;236:35-47.
30. Noldus LP, Spink AJ, Tegelenbosch RA. EthoVision: A versatile video tracking system for automation of behavioral experiments. Behav Res Methods Instrum Comput 2001;33: 398-414.
31. Spink AJ, Tegelenbosch RA, Buma MO et al. The EthoVision video tracking system: A tool for behavioral phenotyping of transgenic mice. Physiol Behav 2001;73:731-744.
32. Schindelin J, Arganda-Carreras I, Frise E et al. Fiji: An open-source platform for biological-image analysis. Nat Methods 2012;9:676-682.
33. Bernard CC, Carnegie PR. Experimental autoimmune encephalomyelitis in mice: Immunologic response to mouse spinal cord and myelin basic proteins. J Immunol 1975;114: 1537-1540.
34. Wilson A, Shehadeh LA, Yu H et al. Agerelated molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 2010;11:229.
35. Zhang DY, Pan Y, Zhang C et al. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production. Mol Cell Biochem 2013;374:13-20.
36. Bork S, Pfister S, Witt H et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010;9:54-63.
37. Gala K, Burdzińska A, Idziak M, et al. Characterization of bone-marrow-derived rat mesenchymal stem cells depending on donor age. Cell Biol Int 2011;35:1055-1062.
38. Awasthi V, King RJ. PKC, p42/p44 MAPK, and p38 MAPK are required for HGF-induced proliferation of H441 cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L942-L949.
39. Efimenko A, Starostina E, Kalinina N et al. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med 2011;9:10.
40. Mohyeddin Bonab M, Yazdanbakhsh S, Lotfi J et al. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 2007;4:50-57.
41. Lee T. Stem cell therapy independent of stemness. World J Stem Cells 2012;4:120-124.
42. Tyndall A. Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am Soc Hematol Educ Program 2011;2011:280-284.